Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4759202
Max Phase: Preclinical
Molecular Formula: C44H78N18O10
Molecular Weight: 1019.22
Molecule Type: Unknown
Associated Items:
ID: ALA4759202
Max Phase: Preclinical
Molecular Formula: C44H78N18O10
Molecular Weight: 1019.22
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)CN)C(=O)NCC(=O)N[C@H](CCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N/C(=C\CCNC(=N)N)C(=O)O
Standard InChI: InChI=1S/C44H78N18O10/c1-25(21-48)35(61-37(65)28(49)10-3-5-15-45)41(69)56-26(2)36(64)54-23-34(63)57-30(12-7-17-47)42(70)62-19-9-14-33(62)40(68)60-32(20-27-22-52-24-55-27)39(67)58-29(11-4-6-16-46)38(66)59-31(43(71)72)13-8-18-53-44(50)51/h13,22,24-26,28-30,32-33,35H,3-12,14-21,23,45-49H2,1-2H3,(H,52,55)(H,54,64)(H,56,69)(H,57,63)(H,58,67)(H,59,66)(H,60,68)(H,61,65)(H,71,72)(H4,50,51,53)/b31-13-/t25-,26-,28-,29-,30+,32-,33-,35-/m0/s1
Standard InChI Key: FWYCMUFYDJSIKO-NQVZSRARSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1019.22 | Molecular Weight (Monoisotopic): 1018.6148 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Loza E,Sarciaux M,Ikaunieks M,Katkevics M,Kukosha T,Trufilkina N,Ryabova V,Shubin K,Pantel L,Serri M,Huseby DL,Cao S,Yadav K,Hjort K,Hughes D,Gualtieri M,Suna E,Racine E. (2020) Structure-activity relationship studies on the inhibition of the bacterial translation of novel Odilorhabdins analogues., 28 (11): [PMID:32279921] [10.1016/j.bmc.2020.115469] |
Source(1):